semaglutide novo nordisk patent Semaglutide's expires today. What does it mean for patients, pharma players and Nordisk? The upcoming expiry of the

If you want to see whether a personalized plan may fit your needs, you can take the free assessment quiz

Starting in the 1980s, a class of appetite-connected molecules termed glucagon-like peptide (GLP-1) antagonists emerged as topics of interest, due to their implications for treating conditions such as type 2 diabetes and obesity

Franco has taken the drug himself, losing about 40 pounds in 11 weeks

Supplementary information Supplementary methods, figures, video captions and references

na podstawie: PAP, EMA PRZEJD DO: OBESITOLOGIA

Zepbound is the tirzepatide brand that is FDA-approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition